Product Images Cymbalta
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 10 images provide visual information about the product associated with Cymbalta NDC 43353-303 by Aphena Pharma Solutions - Tennessee, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Bottle Label 30mg - 43353 303
This is a description of a medication called Duloxetine HCI (Cymbalta) DR 30mg 3060 Capsules. The medicine should be kept between 20-25 degrees Celsius (63-77 degrees Fahrenheit) and stored in a light-resistant container per USP regulations. The manufacturing of the medicine is done by Eli Lilly and Company in Indianapolis whereas the repackaging is done by Aphen Pharma in Cookeville with the NDC# 43353-0303-19. The text possibly includes batch or lot numbers as well but they are not readable by .*
Aphena Pharma Solutions - TN - Aphena
Structural Formula - cymbalta 01
Figure 1 - cymbalta 02
Figure 2 - cymbalta 03
Figure 3 - cymbalta 13
Figure 4 - cymbalta 14
Figure 5 - cymbalta 15
This is a graph showing the percentage of patients improved with the CYM60/120 mg once daily medication and placebo. The x-axis represents the percent improvement in pain from baseline, while the y-axis shows the percentage of patients improved. The graph shows that more patients improved with the medication compared to placebo.*
Figure 6 - cymbalta 16
The given text represents a graph showing the percentage of patients improved on placebo and CYMB0 (a medication) mg once daily. The percentage of improvement is plotted against the percentage improvement in pain from baseline (BOCF). The x-axis represents the percentage improvement in pain from baseline, and the y-axis represents the percentage of patients improved. The graph shows that more patients improved with CYMB0 mg than with placebo.*
Figure 7 - cymbalta 17
This is a graph that displays the percentage of patients who improved with placebo and Cymbalta at 120 mg once daily treatment. The x-axis shows different levels of percent improvement in pain from baseline and the y-axis shows the number of patients. It seems that the percentage of patients who improved is 100%, and the graph shows a comparison between the placebo and Cymbalta treatment.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.